Fantofarone

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameFantofarone
Drug Alias Namefantofarone泛托法隆fantofaronumfantofaronaSR-33557
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockersVoltage-gated L-type calcium channel blockers
TargetsVoltage-gated calcium channelVoltage-gated L-type calcium channel
Therapy Area/IndicationsHypertensionAngina PectorisArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsHypertensionAngina PectorisArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksWikipedia